Conference Track

Global Epidemiology and Management Issues in Resource-Limited Settings

Source: CCO Official Conference Coverage of the 2006 International AIDS Conference

Capsule Summaries

TB Incidence in Senegal Highest in First Year of HAART and In Patients With Advanced Disease, Low Hemoglobin
Estimated HIV-1 Transmission Rate Reduced by 98% After 2 Years of Antiretroviral Therapy and Prevention Counseling in Rural Uganda
Low Baseline CD4+ Cell Count and Poor Adherence Predict Early Mortality in Kenyan HAART Program
Point-of-Care Lactate Testing Improves Management of Symptomatic Hyperlactatemia or Lactic Acidosis in HIV Patients on Antiretrovirals in South Africa
Meta-Analysis Reveals That Patients in Sub-Saharan Africa Adhere Better to Antiretroviral Therapy Than Patients in North America
Dramatic Increase in Number of Women Receiving PMTCT Services Through Routine HIV Testing vs Volunteer HIV Testing
Limited Predictive Value of WHO Clinical and CD4+ Cell Count Criteria for Determining Treatment Failure in Resource-Poor Settings
Cotrimoxazole Prophylaxis and Antiretroviral Therapy Highly Cost-effective in Côte d’Ivoire, Computer Model Estimates
HIV-1 Prevalence, Incidence Stable or Increasing Since 2000 in Urban and Rural Uganda
Mortality 17-Fold Lower in HAART-Treated Patients From African DART Study Compared With Pre-HAART Cohort
Rapid, Massive Antiretroviral Treatment Scale-up Predicted to Have Long-term Economic Benefit for Several Sub-Saharan African Countries
WHO Field Guidelines for Resource-Limited Settings Have Reduce Sensitivity in Identifying Stage I and II Patients Eligible for Antiretroviral Therapy
Herpes Simplex Virus-2 Predominant Cause of Genital Ulcer Disease in Malawi, Associated With HIV-1 Coinfection
Survival Trends in Large Cohort of HIV-Positive South African Miners Similar to Trends in Pre-HAART Western Populations
One Third of Patients on Stavudine, Lamivudine, Plus Nevirapine in a Tanzanian Clinic Experience Virologic Failure; Social Coping May Help

Expert Analysis

Global Epidemiology and Management Issues in Resource-Limited Settings

Begin the Expert Analysis

Faculty:
Michel Kazatchkine, MD Mauro Schechter, MD, PhD Charles van der Horst, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

Recount the data describing the effect of HAART on mortality in HIV-infected populations located in resource-poor settings
Discuss the various available strategies for the prevention, assessment, testing, and treatment of HIV in developing nations
Summarize new data on economic and social issues that affect the optimal management of HIV for patients in resource-poor locations
Describe clinical markers of treatment failure in HIV patients receiving antiretroviral therapy in developing nations

CME CREDIT INFORMATION

Release Date: 10/27/06

Expiration Date: 10/26/07

Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.2 contact hours (0.12 CEUs)

Registered Nurses: 1.4 Nursing CE credits

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.

CCO Resources

CCO Expert Recap of data from the 2006 International AIDS Conference

CCO Expert Recap

Related Content

Other Tracks from this Conference:

First-Line Therapy and Switch Strategies

Resistance and Management of Treatment-Experienced Patients

New Agents and Insights from Basic Science

Clinical Pharmacology and Adverse Events

Metabolic Complications and Lipodystrophy

Hepatitis and Opportunistic Coinfections

Mother-to-Child Transmission and Management of Pediatric HIV Infection